Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

NCT02442466 is registered in ClinicalTrials.gov with MelCure SA as lead sponsor.

NCT NCT02442466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
Lead sponsor
MelCure SA
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2011
Completion date
Not reported
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma